Phase 2a Study of IW-6463 in Adults Diagnosed With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04475549 |
|
Recruitment Status :
Terminated
(Study terminated due to enrollment challenges.)
First Posted : July 17, 2020
Last Update Posted : January 25, 2023
|
Sponsor:
Cyclerion Therapeutics
Information provided by (Responsible Party):
Cyclerion Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | January 23, 2022 |
| Actual Study Completion Date : | January 23, 2022 |
| Certification/Extension First Submitted : | January 20, 2023 |